Drug · DIN 00287725
ESTRAGYN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 18, 2024; first marketed December 31, 1974.
- Drug Identification Number (DIN)
- 00287725
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Natural and semisynthetic estrogens, plain G03CA
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESTERIFIED ESTROGENS | 0.625 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 1, 2015: NOC 16955New Drug Submission (NDS) · Transfer of drug identification numbers
- November 13, 2014: NOC 16278New Drug Submission (NDS) · Transfer of drug identification numbers
- May 23, 2014: NOC 15630New Drug Submission (NDS) · Transfer of drug identification numbers
- September 21, 2010: NOC 11725New Drug Submission (NDS) · Manufacturer and product name change
Other DINs named ESTRAGYN
- DIN 00473618 · Cancelled Post Market